A theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment

被引:58
作者
Hernandez, CJ
Beaupré, GS
Marcus, R
Carter, DR
机构
[1] VA Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr, Palo Alto, CA USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Biomech Engn Div, Dept Engn Mech, Stanford, CA 94305 USA
关键词
alendronate; osteoporosis; computer simulation; bisphosphonates; bone mineral density (BMD);
D O I
10.1016/S8756-3282(01)00613-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with osteoporosis, alendronate treatment causes an increase in bone mineral density (BMD) and a decrease in fracture incidence. Alendronate acts by changing the bone remodeling process. Changes in bone remodeling resulting in decreased remodeling space, increased bone balance per remodeling cycle, and increased mineralization (ash mass/bone mass) have all been associated with alendronate treatment. Understanding the relative contributions of these parameters to BMD increases could help predict the utility of long-term (> 10 years) or intermittent treatment strategies, as well as treatment strategies in which another pharmaceutical is administered concurrently. We have developed a computer simulation of bone remodeling to compare the contributions of focal bone balance and mineralization on BMD by simulating alendronate treatment using a bone balance method (decreased remodeling space, increased focal bone balance, uniform bone mineralization) and a mineralization method (decreased remodeling space, neutral focal bone balance, varying bone mineralization). Although both methods are able to predict BMD increases caused by alendronate over short periods, our findings suggest that the mineralization method may be more descriptive of long-term alendronate treatment. This implies that mineralization may be a larger contributor to BMD changes caused by alendronate than the focal bone balance. Based on this finding we offer a hypothesis to describe how remodeling space, focal bone balance, and mineralization each contribute to alendronate-induced BMD changes. Future analyses with this method could be used to identify improved dosing regimens and to predict which osteoporosis treatments would best complement each other. (C) 2001 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 21 条
[1]   A RECONSTRUCTION OF THE REMODELING CYCLE IN NORMAL HUMAN CORTICAL ILIAC BONE [J].
AGERBAEK, MO ;
ERIKSEN, EF ;
KRAGSTRUP, J ;
MOSEKILDE, L ;
MELSEN, F .
BONE AND MINERAL, 1991, 12 (02) :101-112
[2]  
[Anonymous], 1963, BONE REMODELING DYNA
[3]   Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women [J].
Boivin, GY ;
Chavassieux, PM ;
Santora, AC ;
Yates, J ;
Meunier, PJ .
BONE, 2000, 27 (05) :687-694
[4]   Alendronate and estrogen effects in postmenopausal women with low bone mineral density [J].
Bone, HG ;
Greenspan, SL ;
McKeever, C ;
Bell, N ;
Davidson, M ;
Downs, RW ;
Emkey, R ;
Meunier, PJ ;
Miller, SS ;
Mulloy, AL ;
Recker, RR ;
Weiss, SR ;
Heyden, N ;
Musliner, T ;
Suryawanshi, S ;
Yates, AJ ;
Lombardi, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :720-726
[5]   Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: A histomorphometric analysis of transiliac biopsies [J].
Chavassieux, PM ;
Arlot, ME ;
Roux, JP ;
Portero, N ;
Daifotis, A ;
Yates, AJ ;
Hamdy, NAT ;
Malice, MP ;
Freedholm, D ;
Meunier, PJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) :754-762
[6]   Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis [J].
Chavassieux, PM ;
Arlot, ME ;
Reda, C ;
Wei, L ;
Yates, AJ ;
Meunier, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1475-1480
[7]   ALENDRONATE TREATMENT OF THE POSTMENOPAUSAL OSTEOPOROTIC WOMAN - EFFECT OF MULTIPLE DOSAGES ON BONE MASS AND BONE REMODELING [J].
CHESTNUT, CH ;
MCCLUNG, MR ;
ENSRUD, KE ;
BELL, NH ;
GENANT, HK ;
HARRIS, ST ;
SINGER, FR ;
STOCK, JL ;
YOOD, RA ;
DELMAS, PD ;
KHER, U ;
PRYORTILLOTSON, S ;
SANTORA, AC .
AMERICAN JOURNAL OF MEDICINE, 1995, 99 (02) :144-152
[8]   CANCELLOUS BONE REMODELING IN TYPE-I (POSTMENOPAUSAL) OSTEOPOROSIS - QUANTITATIVE ASSESSMENT OF RATES OF FORMATION, RESORPTION, AND BONE LOSS AT TISSUE AND CELLULAR-LEVELS [J].
ERIKSEN, EF ;
HODGSON, SF ;
EASTELL, R ;
CEDEL, SL ;
OFALLON, WM ;
RIGGS, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (04) :311-319
[9]  
HEANEY RP, 1994, J BONE MINER RES, V9, P1515
[10]   Bisphosphonate effects and the bone remodeling transient [J].
Heaney, RP ;
Yates, AJ ;
Santora, AC .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (08) :1143-1151